Abstract | BACKGROUND: Novel immunotherapies targeting cancer-associated truncated O- glycans Tn (GalNAcα-Ser/Thr) and STn (Neu5Acα2-6GalNacα-Ser/Thr) are promising strategies for cancer treatment. However, no comprehensive, antibody-based mapping of truncated O- glycans in tumours exist to guide drug development. METHODS: We used monoclonal antibodies to map the expression of truncated O- glycans in >700 tissue cores representing healthy and tumour tissues originating from breast, colon, lung, pancreas, skin, CNS and mesenchymal tissue. Patient-derived xenografts were used to evaluate Tn expression upon tumour engraftment. RESULTS: The Tn-antigen was highly expressed in breast (57%, n = 64), colorectal (51%, n = 140) and pancreatic (53%, n = 108) tumours, while STn was mainly observed in colorectal (80%, n = 140) and pancreatic (56%, n = 108) tumours. We observed no truncated O- glycans in mesenchymal tumours (n = 32) and low expression of Tn (5%, n = 87) and STn (1%, n = 75) in CNS tumours. No Tn-antigen was found in normal tissue (n = 124) while STn was occasionally observed in healthy gastrointestinal tissue. Surface expression of Tn-antigen was identified across several cancers. Tn and STn expression decreased with tumour grade, but not with cancer stage. Numerous xenografts maintained Tn expression. CONCLUSIONS: Surface expression of truncated O- glycans is limited to cancers of epithelial origin, making Tn and STn attractive immunological targets in the treatment of human carcinomas.
|
Authors | Troels Boldt Rømer, Mikkel Koed Møller Aasted, Sally Dabelsteen, Aaron Groen, Julia Schnabel, Edwin Tan, Johannes Wirenfeldt Pedersen, Amalie Dahl Haue, Hans Heugh Wandall |
Journal | British journal of cancer
(Br J Cancer)
Vol. 125
Issue 9
Pg. 1239-1250
(10 2021)
ISSN: 1532-1827 [Electronic] England |
PMID | 34526666
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2021. The Author(s), under exclusive licence to Springer Nature Limited. |
Chemical References |
- Antibodies, Monoclonal
- Antigens, Tumor-Associated, Carbohydrate
- Tn antigen
|
Topics |
- Animals
- Antibodies, Monoclonal
(immunology)
- Antigens, Tumor-Associated, Carbohydrate
(metabolism)
- Case-Control Studies
- Down-Regulation
- Gene Expression Regulation, Neoplastic
- Humans
- Mice
- Neoplasm Grading
- Neoplasm Staging
- Neoplasm Transplantation
- Neoplasms
(classification, metabolism, pathology)
- Tissue Array Analysis
(methods)
- Up-Regulation
|